GeneDx Holdings (WGS) Cash from Investing Activities (2020 - 2026)

GeneDx Holdings (WGS) has reported Cash from Investing Activities for 7 consecutive years, with -$5.6 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Cash from Investing Activities rose 84.51% year-over-year to -$5.6 million in Q2 2026; TTM through Jun 2026 was -$38.6 million, a 28.48% increase from a year earlier, with the FY2025 full-year figure at -$61.5 million, down 104.16% from the prior year.
• Cash from Investing Activities was -$5.6 million for Q2 2026 at GeneDx Holdings, up from -$17.3 million in the prior quarter.
• Over five years, Cash from Investing Activities peaked at $843000.0 in Q1 2024 and troughed at -$130.3 million in Q2 2022.
• A 5-year average of -$16.6 million and a median of -$6.7 million in 2024 frame the typical range for Cash from Investing Activities.
• Across the five-year window, Cash from Investing Activities slumped 2807.77% in 2022 and soared 282.47% in 2024, its largest moves.
• Over 5 years, Cash from Investing Activities stood at -$2.8 million in 2022, then sank by 71.39% to -$4.9 million in 2023, then jumped by 89.33% to -$519000.0 in 2024, then plunged by 2033.33% to -$11.1 million in 2025, then surged by 49.15% to -$5.6 million in 2026.
• The last three Cash from Investing Activities figures came in at -$5.6 million (Q2 2026), -$17.3 million (Q1 2026), and -$11.1 million (Q4 2025), per Business Quant data.